Spindle cell lesions of the breast: a diagnostic approach

EA Rakha, E Brogi, I Castellano, C Quinn - Virchows Archiv, 2022 - Springer
Spindle cell lesions of the breast comprise a heterogeneous group of lesions, ranging from
reactive and benign processes to aggressive malignant tumours. Despite their rarity, they …

[HTML][HTML] Fibroepithelial lesions revisited: implications for diagnosis and management

PH Tan - Modern Pathology, 2021 - Elsevier
Fibroepithelial lesions of the breast, comprising the fibroadenoma and phyllodes tumour, are
a unique group of neoplasms that share histological characteristics but possess different …

Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists

C Sars, H Sackey, J Frisell, PW Dickman… - Breast cancer research …, 2023 - Springer
Purpose Phyllodes tumors of the breast are rare fibroepithelial lesions that are classified as
benign, borderline or malignant. There is little consensus on best practice for the work-up …

Survey of recurrent diagnostic challenges in breast phyllodes tumours

BY Tan, SB Fox, SR Lakhani, PH Tan - Histopathology, 2023 - Wiley Online Library
Background Breast phyllodes tumours (PTs) are graded as benign, borderline, or malignant
by analysis of multiple histological features. PT grading is often inconsistent, likely due to …

Fibroepithelial tumours of the breast—a review

MF Lerwill, AHS Lee, PH Tan - Virchows Archiv, 2022 - Springer
Fibroepithelial tumours of the breast are biphasic neoplasms composed of both epithelial
and stromal elements, including the common fibroadenoma and the infrequent phyllodes …

Genomic characterisation of breast fibroepithelial lesions in an international cohort

ND Md Nasir, CCY Ng, V Rajasegaran… - The Journal of …, 2019 - Wiley Online Library
Fibroepithelial lesions (FELs) are a heterogeneous group of tumours comprising
fibroadenomas (FAs) and phyllodes tumours (PTs). Here we used a 16‐gene panel that was …

Uncommon and peculiar soft tissue sarcomas: multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS–GROUP). Part II

J Martínez-Trufero, JC Jurado… - Cancer treatment …, 2021 - Elsevier
Abstract Among all Soft Tissue sarcomas there are some subtypes with low incidence and/or
peculiar clinical behaviour, that need to be consider separately. Most of them are orphan …

Next‐generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction

M Nourieh, R Vibert, M Saint‐Ghislain, J Cyrta… - …, 2023 - Wiley Online Library
The diagnosis, histomolecular classes of breast cancers (luminal A, luminal B, HER2‐
enriched, and basal‐like), and accurate prediction of prognosis are commonly determined …

[HTML][HTML] Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis

F Beca, G Krings, YY Chen, EM Hosfield, P Vohra… - Modern Pathology, 2020 - Elsevier
Angiosarcoma (AS) is the most frequent primary sarcoma of the breast but nevertheless
remains uncommon, accounting for< 0.05% of breast malignancies. Secondary mammary …

Sarcoma of the breast: Breast cancer history as etiologic and prognostic factor—A population-based case–control study

F Karlsson, F Granath, KE Smedby, J Zedenius… - Breast Cancer Research …, 2020 - Springer
Purpose Sarcomas of the breast account for about 1% of all breast malignancies. The aim of
this national survey was to explore etiologic and prognostic factors. Methods Utilizing …